ASTRANA HEALTH INC

ASTH is the ticker symbol for Astrana Health, Inc., a healthcare company that operates a network of primary care clinics and manages care for patients, primarily in California. The company focuses on value-based care, aiming to improve patient outcomes while reducing costs. ASTH stock represents an ownership stake in this publicly traded healthcare organization.

The 52-week range shows the lowest and highest prices at which ASTH has traded over the past year. This range helps investors gauge the stock's volatility and price history. For the most current 52-week range, please refer to the latest ASTH data displayed on this page, as market prices change frequently.

Volatility measures how much ASTH's price fluctuates over time. Like many healthcare stocks, ASTH can experience price swings due to factors such as earnings reports, regulatory changes, and broader market conditions. Its volatility may be influenced by its market capitalization, trading volume, and investor sentiment. For specific volatility metrics, consult the latest ASTH data on this page.

Evaluating ASTH's valuation involves analyzing metrics such as the price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and enterprise value-to-EBITDA. Comparing these to industry peers and ASTH's historical averages can provide context. Additionally, consider growth prospects, profitability, and balance sheet strength. Current valuation metrics for ASTH can be found in the latest data on this page.

Astrana Health does not currently pay a dividend to shareholders. Instead, the company likely reinvests earnings into growth initiatives and operations. Investors seeking income should note that ASTH is not a dividend-paying stock. For any updates on dividend policy, check the latest ASTH data on this page.

Key risks for ASTH include regulatory changes in healthcare, reimbursement rate pressures, competition, and integration risks from acquisitions. Economic downturns could also affect patient volumes and payer mix. Additionally, the company's focus on value-based care models may face operational challenges. Investors should review ASTH's financial statements and risk disclosures for a comprehensive view.